Certara
The global leader in model-informed drug development and regulatory science, focused on optimizing drug development and improving health outcomes.
Certara is the best-in-class provider of regulatory science, writing, and submission management software and services
- Sector
Healthcare
- Country
United States
- Fund
EQT VIII
- Entry
2017
- Exit
2022
Website
About Certara
Certara is the leading provider of model-informed drug development technology and services, as well as a best-in-class provider of regulatory science, writing, and submission management software and services. Certara’s solutions help inform the drug development and regulatory approval process and address the key efficacy, safety, productivity and commercial challenges facing the biopharma industry. The Company serves 1,200 commercial companies, 250 academic institutions and numerous regulatory agencies, across 60 countries. Certara is headquartered in Princeton, New Jersey with over 850 employees globally, including key operations and senior management in Northern Europe.
Do You Want to Know More?
We are eager to explore how we can achieve great things together.